跳至主要内容
临床试验/NCT04398875
NCT04398875Unknown不适用

The Adjunctive Effect of Acupuncture for Advanced Cancer Patients in a Collaborative Model of Palliative Care: a Three-arm Pragmatic Randomized Trial

The University of Hong Kong0 个研究点目标入组 120 人开始时间: 2020年9月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
120
主要终点
Change of the symptom improvments

研究概览

简要总结

The proposed study aims to evaluate the adjunctive effect of MA with standard care (ASC) for relieving cancer-related symptoms in a collaborative model of palliative care compared to sham MA plus standard care (SSC) or standard care alone (SC).

详细描述

After being informed about the study plan, potential risk and benefits, all subjects will give written informed consent prior to participation and undergo eligibility screening. Eligible participants will be randomized into three arms, ASC, SSC, and SC, in a 2:1:1 ratio.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

Subjects randomly assigned to either ASC group or SSC group will be blinded to their group assignment

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All cases are subject to pathology and (or) cytology for a diagnosis of malignant tumour (pathological type is not restricted) at stage IIIB or IV;
  • Aged 18 years or above;
  • Expected survival time longer than 16 weeks;

排除标准

  • Disseminated intravascular coagulation or severe thrombocytopenia with a bleeding tendency, i.e., low platelet count < 35000/µL; INR > 1.5; hemoglobin ≤ 90 g/dL; white blood cell count ≤ 4x109/L;
  • Uncontrolled active skin infection;
  • Needle phobia;
  • Inability to read and understand Chinese;
  • Not signed written informed consent.
  • Receiving surgery during the whole study period;
  • Receiving acupuncture treatment in the last 3 months

结局指标

主要结局

Change of the symptom improvments

时间窗: Change from baseline score at 3 weeks

The Edmonton Symptom Assessment System (ESAS) is used to rate the intensity of nine common symptoms experienced by cancer patients. Each symptom is scored from 0 to 10. (0 indicats no symptom and 10 indicates the worst symptom)

次要结局

  • EORTC QLQ-C15-PAL(weeks 0, 3, 7 and 11)
  • Numeric Rating Scale(weeks 0, 3, 7 and 11)
  • Symptom improvments(weeks 0, 1, 2, 7 and 11)
  • The Insomnia Severity Index(weeks 0, 3, 7 and 11)
  • Fatigue(weeks 0, 3, 7 and 11)
  • The Hospital Anxiety and Depression Scale(weeks 0, 3, 7 and 11)

研究者

申办方类型
Other
责任方
Sponsor

相似试验